1. "Urology"
  2. "Oxford University Press"
Formats
  1. Journal Article (36)
  2. Meeting Abstract (11)
  3. Editorial (2)
  4. Guidelines (1)
  5. Research Letter (1)
  6. Review (1)
Groups
  1. Surgery (52)
  2. Urology (52)
  3. Population Sciences Research Program (31)
  4. Epidemiology and Biostatistics (30)
  5. Health Outcomes Research Group (18)
  6. Department of Medicine (17)

More Groups

People
  1. Hans Lilja (11)
  2. Andrew Vickers (10)
  3. Sigrid Carlsson (10)
  4. Abraham Hakimi (8)
  5. Paul Russo (7)
  6. Carlos Cordon-Cardo (6)

More People

Years
  1. 2024 (4)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (6)
  5. 2020 (4)
  6. 2019 (2)

More Years

Publications
  1. JNCI: Journal of the National Cancer Institute (23)
  2. Annals of Oncology (13)
  3. The Oncologist (6)
  4. American Journal of Epidemiology (2)
  5. Human Molecular Genetics (2)
  6. Briefings in Bioinformatics (1)

More Publications

Publishers
  1. Oxford University Press (52)

Results (52)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pre-surgical visceral adipose tissue may be a novel pre-surgical risk factor for acute kidney injury among clear cell renal cell cancer patients undergoing radical nephrectomy
    Meeting Abstract

    Sanchez, A.; Olson, L.; Knezevic, A.; Akin, O.; Scott, J. S.; Mourtzakis, M.; Hakimi, A. A.; Russo, P.; Jaimies, E.; Bradshaw, P.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Circulating leptin and immune-related transcriptomic patterns in clear cell renal cell carcinoma
    Meeting Abstract

    Posada Calderon, L.; Olsson, L.; Kuo, F.; Dawidek, M.; Barbakoff, D.; Ganz, M.; Jiang, H.; Coleman, J. A.; Russo, P.; Furberg, H.; more...
    The Oncologist (2024)

    Fulltext@MSK | Save
  • Implementation of physical therapist services for men undergoing radical prostatectomy: An administrative case report
    Journal Article

    Wolden, M.; Brown, S.; Carlsson, S. V.; Noah, T. A.; Mungovan, S. F.
    Physical Therapy (2024)

    Fulltext@MSK | Save
  • Molecular features of prostate cancer after neoadjuvant therapy in the phase 3 CALGB 90203 trial
    Journal Article

    Sumiyoshi, T.; Wang, X.; Warner, E. W.; Sboner, A.; Annala, M.; Sigouros, M.; Beja, K.; Mizuno, K.; Ku, S.; Fazli, L.; more...
    JNCI: Journal of the National Cancer Institute (2024)

    Fulltext@MSK | Save
  • Functional and translational consequences of immunometabolic coevolution in ccRCC
    Meeting Abstract

    Reznik, E.; Tang, C.; Xie, A.; Liu, E. M.; Kuo, F.; Kim, M.; Golkaram, M.; Chen, Y.; Gupta, S.; Motzer, R.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Adjuvant nivolumab plus ipilimumab (NIVO+IPI) vs placebo (PBO) for localized renal cell carcinoma (RCC) at high risk of relapse after nephrectomy: Results from the randomized, phase III CheckMate 914 trial
    Meeting Abstract

    Motzer, R. J.; Russo, P.; Gruenwald, V.; Tomita, Y.; Zurawski, B.; Parikh, O. A.; Buti, S.; Barthelemy, P.; Goh, J. C. H.; Ye, D.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Response to Takahashi
    Editorial

    Borregales, L. D.; DeMeo, G.; Gu, X.; Cheng, E.; Dudley, V.; Schaeffer, E. M.; Nagar, H.; Carlsson, S.; Vickers, A.; Hu, J. C.
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Grade migration of prostate cancer in the United States during the last decade
    Journal Article

    Borregales, L. D.; DeMeo, G.; Gu, X.; Cheng, E.; Dudley, V.; Schaeffer, E. M.; Nagar, H.; Carlsson, S.; Vickers, A.; Hu, J. C.
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • A phase Ib study of enzalutamide (Enza) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Zhao, J. L.; Antonarakis, S.; Cheng, H.; George, D. J.; Aggarwal, R. R.; Abida, W.; Decker, B.; Smart-Curley, T.; Schonhoft, J.; Anderson, A.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Biochemical response (PSA0) and testosterone (T) recovery in Metacure, a multi-arm multi-modality (MM) therapy (tx) for very high risk localized (HRL) and low volume metastatic (LVM) prostatic adenocarcinoma
    Meeting Abstract

    Teo, M. Y.; McBride, S.; Gopalan, A.; Benoliel, H.; Eastham, J. A.; Goh, A.; Szmulewitz, R.; Morgans, A. K.; Bubley, G.; Gupta, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save